Journey Medical Corporation (NASDAQ: DERM)
$5.75
-0.1600 ( -2.71% ) 52.3K
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Market Data
Open
$5.75
Previous close
$5.91
Volume
52.3K
Market cap
$114.67M
Day range
$5.73 - $6.10
52 week range
$1.60 - $8.11
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 08, 2023 |
4 | Insider transactions | 1 | Sep 08, 2023 |
8-k | 8K-related | 14 | Sep 06, 2023 |
8-k | 8K-related | 12 | Aug 18, 2023 |
10-q | Quarterly Reports | 87 | Aug 10, 2023 |
8-k | 8K-related | 14 | Aug 08, 2023 |
8-k | 8K-related | 12 | Jul 26, 2023 |
4 | Insider transactions | 1 | Jul 25, 2023 |
4 | Insider transactions | 1 | Jul 25, 2023 |
4 | Insider transactions | 1 | Jul 25, 2023 |